Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intersystem crossing and spin dynamics of thionated perinones: combined steady-state/transient optical and electron paramagnetic resonance spectral analysis.

Physical chemistry chemical physics : PCCP·2026
Same author

Twisted Anthracene-Fused BODIPY: Intersystem Crossing and Torsion-Induced Non-Radiative Relaxation of the Singlet Excited State.

Molecules (Basel, Switzerland)·2026
Same author

Photophysical properties of perylenebisimide derivatives studied by time-resolved transient optical and electron paramagnetic resonance spectroscopy.

The Journal of chemical physics·2025
Same author

Thionated Perylenebisimides as Heavy-Atom-Free Triplet Photosensitizers: Intersystem Crossing, Electron Spin Dynamics, and Application in Photodynamic Therapy.

Angewandte Chemie (International ed. in English)·2025
Same author

Thionated Coumarins: Study of the Intersystem Crossing and the Zero-field Splitting of the Triplet State Using Time-Resolved Transient Optical and Electron Paramagnetic Resonance Spectroscopies.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Excited state dynamics of a Bodipy derivative with a twisted molecular structure: Combined experimental and theoretical studies.

The Journal of chemical physics·2025

Related Experiment Video

Updated: Jul 5, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.

Jana Henschkowski1, Andreas E Stuck, Brigitte M Frey

  • 1Department of Geriatrics, Inselspital University Hospital, Berne, Switzerland.

American Journal of Hypertension
|April 30, 2008
PubMed
Summary
This summary is machine-generated.

Reduced 11beta-HSD2 activity is linked to age-related arterial hypertension. This impairment compromises cortisol inactivation, potentially driving hypertension in older adults and offering new treatment targets.

Related Experiment Videos

Last Updated: Jul 5, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Area of Science:

  • Endocrinology
  • Gerontology
  • Cardiovascular Medicine

Background:

  • Arterial hypertension prevalence increases with age, often without a clear cause.
  • Age-related hypertension mechanisms are poorly understood but may involve mineralocorticoid receptor overactivation.
  • A hypothesis suggests age-dependent impairment of 11beta-HSD2 activity leads to cortisol-mediated hypertension.

Purpose of the Study:

  • To investigate the hypothesis that 11beta-HSD2 activity is age-dependently impaired.
  • To determine if impaired 11beta-HSD2 activity contributes to age-related arterial hypertension.

Main Methods:

  • Analyzed urinary steroid hormone metabolites (cortisol, cortisone, and their metabolites) in 165 hypertensive patients using gas chromatography-mass spectrometry.
  • Assessed apparent 11beta-HSD2 and 11beta-hydroxylase activity and cortisol metabolite excretion.
  • Correlated metabolite levels and enzyme activities with patient age.

Main Results:

  • Age positively correlated with ratios suggesting reduced 11beta-HSD2 activity (THF+5alphaTHF)/THE and F/E.
  • Reduced 11beta-HSD2 activity was observed even after excluding patients with impaired renal function.
  • Cortisol metabolite excretion was age-independent, likely due to diminished 11beta-hydroxylase activity.

Conclusions:

  • Reduced 11beta-HSD2 activity is a novel risk factor for hypertension in the elderly.
  • This finding provides new avenues for developing targeted treatments for age-related hypertension.